Arkolith/Insider Trading/ADPT/Form 4

Rubinstein Julie

President and COOAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 24, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$798K
Net Open-Market Flow
-$798K
Transactions
9
6 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 24, 2026Option exercise(M)15K$8.46$125K401K
Apr 24, 2026Sell(S)19K$14.02$267K382K
Apr 23, 2026Option exercise(M)15K$8.46$125K406K
Apr 23, 2026Sell(S)19K$13.74$262K386K
Apr 22, 2026Option exercise(M)15K$8.46$125K410K
Apr 22, 2026Sell(S)19K$14.13$269K391K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 24, 2026Option exercise(M)15K—$060K
Apr 23, 2026Option exercise(M)15K—$075K
Apr 22, 2026Option exercise(M)15K—$090K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780664-26-000030) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML